Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Mark Bates

Interventional Cardiology Charleston, WV Medical Doctor

NPI 1720076334 CMS profile 32747

2345 Chesterfield Ave, Suite 302, Charleston, WV 25304

Open in the dashboard

General payments

$288,077

36 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$3

3 holdings reported · through program year 2025

Through program year 2025, Mark Bates of Charleston, WV is reported in the CMS Open Payments database as having received $288,077 across 36 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $3 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $149 1
2021 General $51,214 3
2020 General $89,460 8
2019 General $147,255 24
2021 Ownership $1 1
2020 Ownership $1 1
2019 Ownership $1 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Mark Bates
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Mark Bates were reported at $149. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Mark Bates Interventional Cardiology median Middle half National median
2019 $147,255 $1,097 $329–$3,048 $163
2020 $89,460 $473 $161–$1,480 $114
2021 $51,214 $677 $233–$1,827 $132
2022 $0 $978 $333–$2,724 $149
2023 $0 $1,136 $382–$2,986 $160
2024 $0 $1,181 $395–$3,326 $164
2025 $149 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. W. L. Gore & Associates, Inc. $228,341 27 payments
  2. CeloNova BioSciences, Inc. $59,251 3 payments
  3. Siemens Medical Solutions USA, Inc. $226 2 payments
  4. Edwards Lifesciences Corporation $149 1 payment
  5. Medtronic, Inc. $46 1 payment
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $42 1 payment
  7. Medtronic Vascular, Inc. $22 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $279,706 8 payments
  2. Travel and Lodging $6,954 5 payments
  3. Food and Beverage $1,417 23 payments
Products named General payments · program years 2019–2025
  1. Product in Development $227,255 13 payments
  2. Conformable TAG Thoracic Endoprosthesis $791 6 payments
  3. EXCLUDER AAA Endoprosthesis $155 2 payments
  4. SAPIEN 3 Ultra RESILIA $149 1 payment
  5. Sequoia $108 1 payment
  6. VIABAHN Endoprosthesis with Heparin Bioactive Surface $77 2 payments
  7. 3F $46 1 payment
  8. TAG Thoracic Endoprosthesis $43 2 payments
  9. LifeVest $42 1 payment
  10. CoreValve Evolut $22 1 payment
  11. Other $21 2 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

36 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in West Virginia

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record